With $55 billion earmarked to bolster its U.S. operations, Johnson & Johnson is the latest drugmaker to zero in on expansion plans that are aimed, at least in part, at abating the Trump administration’s pharmaceutical tariff threats.
J&J fleshes out US investment plan, telegraphing $1B cell therapy plant and 500 new jobs in PA
Latest from Blog
NEWS CENTER Maine
Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Four Rules for Fueling that Every Senior Cyclist Should Follow, According to a Dietitian and Cycling Coach
Thankfully, the era of “eating is cheating” is over. Post Views: 2
It’s Nutrition and Hydration Week — Here’s some tips on how to eat healthy on a budget
This week is Nutrition and Hydration Week, an annual week aimed at highlighting and promoting improvements in nutrition and hydration. Local organizations like Second Harvest Food Bank said eating wel… Post Views:
STAT+: Automatic enrollment in Medicare Advantage plans under consideration, top Trump health official says
President Trump’s Medicare director said Thursday his team is considering a policy that would automatically enroll Medicare beneficiaries into Medicare Advantage plans, a controversial idea that was touted in the conservative Project